We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

135 hedge funds and large institutions have $262M invested in Immunogen Inc in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more capital invested

Capital invested by funds: $137M → $262M (+$125M)

5% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 40

13% less funds holding

Funds holding: 156 → 135 (-21)

30% less call options, than puts

Call options by funds: $760K | Put options by funds: $1.09M

44% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 32

Holders
135
Holders Change
-21
Holders Change %
-13.46%
% of All Funds
3.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
38
Reduced
40
Closed
32
Calls
$760K
Puts
$1.09M
Net Calls
-$329K
Net Calls Change
+$160K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$15.6M
2
RG
Redmile Group
California
+$11.6M
3
ClearBridge Investments
ClearBridge Investments
New York
+$2.58M
4
Ameriprise
Ameriprise
Minnesota
+$1.15M
5
SSA
Schonfeld Strategic Advisors
New York
+$730K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.24M
2
Primecap Management
Primecap Management
California
-$3.17M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.93M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.29M
5
Two Sigma Investments
Two Sigma Investments
New York
-$708K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.7M +$171K +58,516 +15%
Ameriprise
27
Ameriprise
Minnesota
$1.53M +$1.15M +394,770 New
Charles Schwab
28
Charles Schwab
California
$1.28M -$201K -68,789 -17%
Natixis Advisors
29
Natixis Advisors
Massachusetts
$1.16M +$42.7K +14,629 +5%
KBC Group
30
KBC Group
Belgium
$1.16M +$52.2K +17,893 +6%
MSAM
31
Moloney Securities Asset Management
Missouri
$1.06M +$213K +72,900 +36%
Fisher Asset Management
32
Fisher Asset Management
Washington
$982K +$14.9K +5,100 +2%
TCIM
33
TIAA CREF Investment Management
New York
$947K -$53.6K -18,366 -7%
TA
34
Teachers Advisors
New York
$734K -$59.3K -20,316 -10%
JP Morgan Chase
35
JP Morgan Chase
New York
$725K +$545K +186,730 +37,346%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$642K -$21.9K -7,500 -4%
Swiss National Bank
37
Swiss National Bank
Switzerland
$617K – – –
AllianceBernstein
38
AllianceBernstein
Tennessee
$458K -$101K -34,700 -23%
TFCP
39
Twin Focus Capital Partners
Massachusetts
$438K – – –
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$432K -$14K -4,800 -4%
DADC
41
D.A. Davidson & Co
Montana
$409K +$1.81K +622 +0.6%
Citigroup
42
Citigroup
New York
$400K -$293K -100,302 -49%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$395K -$12.3K -4,226 -4%
UBS Group
44
UBS Group
Switzerland
$387K -$38.2K -13,077 -12%
Stifel Financial
45
Stifel Financial
Missouri
$382K +$37.7K +12,907 +14%
State Board of Administration of Florida Retirement System
46
State Board of Administration of Florida Retirement System
Florida
$362K – – –
GCP
47
GSA Capital Partners
United Kingdom
$331K +$138K +47,400 +124%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$326K +$3 +1 +0%
CS
49
Credit Suisse
Switzerland
$284K -$324K -110,883 -60%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$279K +$13.7K +4,705 +7%
1
2
3 4 5

IMGN Hedge Fund Activity: Q1 2017 in Review

135 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2017, worth a combined $262M — up 91% from $137M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of IMGN and 18 opened new positions — a net loss of 14 holders — while 40 trimmed existing stakes and 38 added.

The largest buyer was BlackRock, adding an estimated $15.6M. The largest seller was Millennium Management, cutting an estimated $3.24M.

  • 135 institutional investors held Immunogen Inc (IMGN) as of Q1 2017, down from 156 in Q4 2016.
  • Funds reported $262M of Immunogen Inc stock for Q1 2017, up 91% quarter-over-quarter.
  • 18 funds opened new Immunogen Inc positions in Q1 2017 and 32 closed out, a net change of -14 holders.
  • The largest Immunogen Inc buyer in Q1 2017 was BlackRock, an estimated $15.6M added.
  • The largest Immunogen Inc seller in Q1 2017 was Millennium Management, an estimated $3.24M sold.

Based on aggregated 13F filings for Q1 2017.